(3 years, 6 months ago)
Commons ChamberThis issue is very much the subject of debate in the Environment Bill, which is currently going through both Houses of Parliament. We will be setting targets for clean air, and we will also be looking at a population exposure target, since it is not just about the absolute levels of particulate matter—we want to continue to reduce those—but about looking at the issue of population exposure, too.
Topicals are meant to be brief, so you will have a brief answer, Secretary of State.
(7 years, 10 months ago)
Public Bill CommitteesI thank the hon. Gentleman. I have had a quick chat with the Minister, and the lease is for 150 years on everything. On the properties, it will be a 150-year lease. Would my hon. Friend the Minister like to say something?
The intention, as I understand it, is to extend the maximum term of the lease from 31 years to 150 years, and several leases may be granted, as the hon. Member for Wolverhampton South West pointed out—there could be several leases on different properties. The crucial thing, however, is that in my reading of the Bill, to answer the point made by my hon. Friend the Member for The Cotswolds, the grant would be for a lease of a maximum term of 150 years in the normal way of other leases. My hon. Friend also asked whether, in 150 years’ time, that could be considered again and a future Minister 150 years from now could decide to grant a new 150-year lease. I do not see anything in the Bill to prohibit that. The crucial thing, however, is the maximum, which is 31 years but will move to 150 years, subject to the approval of the Secretary of State at the time.
(9 years, 6 months ago)
Westminster HallWestminster Hall is an alternative Chamber for MPs to hold debates, named after the adjoining Westminster Hall.
Each debate is chaired by an MP from the Panel of Chairs, rather than the Speaker or Deputy Speaker. A Government Minister will give the final speech, and no votes may be called on the debate topic.
This information is provided by Parallel Parliament and does not comprise part of the offical record
It is a pleasure to serve under your chairmanship, Mr Davies. I congratulate the hon. Member for Newport East (Jessica Morden) on securing the debate. She has championed this cause for some time and she made it clear towards the end of the last Parliament that she would seek an early opportunity for a debate. She has succeeded. Everyone here will have been touched by the story of her constituent and his ill health.
I am sympathetic to farmers suffering from ill health and I acknowledge that some of them associate their illness with the use of organophosphate sheep dips. There is a long history of research into the hypothesis that low-level and non-toxic exposure to organophosphates, sheep dips in particular, might have caused long-term neurological health conditions.
The independent Committee on Toxicity released a statement on organophosphates in March last year, following its earlier report in 1999. The COT reviewed the science published since the original 1999 report and in summary concluded that the reviewed evidence suggests that exposures to cholinesterase-inhibiting organo- phosphates that are insufficient to cause overt acute poisoning do not cause important long-term neurological toxicity in adults and that, if toxic effects on the nervous system do occur, they are minor and subtle.
I am sorry, but I really must take issue with that; that is not the case. My constituency covers Exmoor and one of my constituents, George Wescott, has suffered with this for more than 30 years. As the hon. Member for Newport East (Jessica Morden) and I have already said, the Minister should set up a commission so that we can get to the bottom of the issue rather than accepting what I suspect is slightly flawed science, although I hesitate to say that.
It is worth looking further at the science, because the committee’s statement was also endorsed by the medical and scientific panel, which is a sub-group of the independent Veterinary Products Committee. A cross-Government official group on organophosphates also endorsed it. It is worth highlighting some extracts from that detailed report. I have read the report, which is very scientific; I recommend it to anyone with an interest.
The report highlighted that, since 1999, 13 new papers have been published on the relation of low-level exposure to organophosphates and peripheral neuropathy, which added to the 13 studies already available at the time of the previous COT report. Having reviewed all 26 of those studies, the report concluded:
“The current balance of evidence suggests that there is no long-term risk of clearly demonstrable peripheral neuropathy from exposure to organophosphates”.